Elspar and leukaemia recurrent Patient Reports February 12, 2012

Elspar Side Effects Report #4570424-0
Elspar side effect was reported by a Physician from on Jan 14, 2005. Male patient, child 9 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Elspar. After drug was administered, patient experienced the following side effects: embolic cerebral infarction, leukaemia recurrent. Elspar dosage: unknown. During the same period patient was treated with METHOTREXATE, PREDNISONE, VINCRISTINE SULPHATE. Patient recovered.

Elspar Side Effects Report #4586975-9
Elspar side effect was reported by a Physician from on Jan 20, 2005. Male patient, child 9 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Elspar. After drug was administered, patient experienced the following side effects: convulsion, embolic cerebral infarction, leukaemia recurrent. Elspar dosage: unknown. During the same period patient was treated with METHOTREXATE, PREDNISONE, VINCRISTINE SULPHATE. Patient recovered.

Elspar Side Effects Report #5764173-0
Elspar side effect was reported by a Consumer or non-health professional from UNITED STATES on May 23, 2008. Male patient, child 4 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Elspar. After drug was administered, patient experienced the following side effects: cystitis haemorrhagic, leukaemia recurrent, mucosal inflammation, pulmonary veno-occlusive disease, venoocclusive liver disease. Elspar dosage: unknown. During the same period patient was treated with VINCRISTINE, PREDNISONE, METHOTREXATE, TENEPOSIDE, CYTARABINE. Patient was hospitalized. Patient recovered.

Elspar Side Effects Report #4561835-8
Elspar side effect was reported by a Physician from on Jan 14, 2005. Female patient, 18 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Elspar. After drug was administered, patient experienced the following side effects: blood fibrinogen decreased, cerebrovascular accident, leukaemia recurrent, plasminogen decreased, subclavian vein thrombosis. Elspar dosage: unknown. During the same period patient was treated with DAUNORUBICIN, VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient recovered.


Elspar Side Effects Report #4564794-7
Elspar side effect was reported by a Physician from on Jan 14, 2005. Female patient, 18 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Elspar. After drug was administered, patient experienced the following side effects: blood fibrinogen decreased, cerebral infarction, cerebrovascular accident, leukaemia recurrent, plasminogen decreased, subclavian vein thrombosis, vascular occlusion. Elspar dosage: unknown. During the same period patient was treated with DAUNORUBICIN, VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient recovered.

Elspar Side Effects Report #4562562-3
Elspar side effect was reported by a Physician from on Jan 14, 2005. Female patient, 15 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Elspar. After drug was administered, patient experienced the following side effects: diabetes mellitus, hypersensitivity, leukaemia recurrent, pancreatitis, renal failure acute. Elspar dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DAUNORUBICIN, METHOTREXATE, PREDNISONE. Patient died.

Elspar Side Effects Report #5089458-5
Elspar side effect was reported by a Health Professional from JAPAN on Aug 09, 2006. Male patient, 14 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Elspar. After drug was administered, patient experienced the following side effects: blood thrombin decreased, convulsion, depressed level of consciousness, gait disturbance, haemorrhagic cerebral infarction, hemiplegia, hypocoagulable state, leukaemia recurrent. Elspar dosage: unknown. Patient recovered.

Elspar Side Effects Report #4586222-8
Elspar side effect was reported by a Consumer or non-health professional from on Jan 14, 2005. Female patient, 13 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Elspar. After drug was administered, patient experienced the following side effects: ileus paralytic, leukaemia recurrent, pancreatic pseudocyst, pancreatitis acute. Elspar dosage: unknown. During the same period patient was treated with PREDNISONE, MERCAPTOPURINE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient died.